2025年“小而美”私募热搜榜揭晓！观理、智信融科领衔，凌鹏、林健伟、许琼娜居前！

Core Viewpoint - The article highlights the rise of "small and beautiful" private equity firms in China, which are defined as those managing less than 2 billion yuan, accounting for 93.39% of the total 7,522 private equity firms by the end of 2025. These firms have shown impressive performance in the slow bull market of 2025, leveraging their agility and focused investment strategies to become market favorites [2][3]. Summary by Sections Industry Overview - As of December 2025, there are 7,522 private equity firms in China, with 7,025 classified as "small and beautiful" (under 2 billion yuan), representing 93.39% of the total [2]. - In the 2025 slow bull market, many of these smaller firms have excelled due to their flexible management and focused investment strategies, distinguishing themselves from larger firms [3]. Performance Metrics - The average returns for various firm sizes in 2025 are as follows: - Over 10 billion yuan: 31.47% - 5-10 billion yuan: 33.62% - 0-5 billion yuan: 32.53% - Overall average: 32.19% [3]. - The "small and beautiful" firms are likened to elite special forces, with streamlined teams and clear investment strategies, which have been amplified in the 2025 market conditions [3]. Popular Firms and Managers - The most popular "small and beautiful" private equity firms in 2025 include: 1. Guanli Fund 2. Zhixin Rongke 3. Deyuan Investment 4. Yizu Investment 5. Shanghai Zijie Private Equity [4]. - The top 10 popular fund managers include: - Ling Peng from Huangyuan Investment - Lin Jianwei from Yizu Investment - Xu Qiongna from Bamai Private Equity [9][12]. Popular Products - The top products among "small and beautiful" private equity firms in 2025 are primarily subjective long strategies, with notable mentions including: - Longhui Xiang Investment's "Longhui Xiang No. 1" - Hunan Zijin's "Zijin Yunsong" - Xingbidada's products [15][18]. - The performance of these products has been significant, with many achieving high returns, although specific figures are not disclosed due to compliance requirements [20].